Boston Scientific Corp

NYSE: BSX
$88.72
+$0.24 (+0.3%)
Closing Price on November 12, 2024

BSX Articles

Thursday's top analyst upgrades, downgrades and initiations include Amazon.com, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie & Fitch.
The sell-off was long overdue, and it may prove to be the pause that refreshes. One thing is for sure, executives and 10% owners were out in full force buying this past week.
Boston Scientific shares are up almost 50% in the past six months, and the stock has more than doubled from two years ago. The question is whether this turnaround can keep turning around.
24/7 Wall St. has already highlighted the worst performing S&P 500 stocks of 2015, and now wants to highlight the best performing S&P 500 stocks of 2015.
Friday's top analyst upgrades and downgrades include Carnival, Ericsson, Honeywell, Pier 1, Tesoro and Trimble Navigation.
Merrill Lynch has weighed in on Boston Scientific acquiring the American Medical Systems urology portfolio of Endo International.
Boston Scientific is pushing forward in its long turnaround and is gathering more speed.
Friday's top analyst upgrades, downgrades and initiations include Cameron International, Dollar General, Genworth Financial, Groupon, SunPower, Visa and Yahoo.
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
Oppenheimer has released its list of potential post-election winners in the medical device industry.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Thursday, October 23, 2014.
24/7 Wall St. would ask if this turnaround in Boston Scientific earnings and outlook is really convincing investors.
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 29, 2014. They include AcelRx, Alcoa, Costco, Lululemon, Walmart and Trulia.
While the name of Stifel's portfolio may be amusing, the idea behind it makes good sense. We picked one stock from each sector in the portfolio to give readers an idea of What Stifel thinks will work...
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Wednesday, April 23, 2014. They include Allergan, Galmed Pharmaceuticals, GM, Sirius XM and SunPower.